The trial will be a multi-center, open-label study involving 75 patients and evaluating multiple INF904 dosing ... data and provide signs of clinical benefit, and to inform the design of a Phase 2b ...

Cash, cash equivalents, and marketable securities of $360.1 million at Q3 2024 - CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical ...

You're in luck - I'm a Sustainability Editor who's passionate about shopping less and investing wisely, and I get to work ...

Cassava Sciences has faced a lot of scrutiny, with key figures resigning and the company settling an SEC penalty. Read what ...

Our selection of the best climbing shoes for crag days and gym sessions, whether you’re into bouldering, trad or sport ...

The best sustainable and eco-friendly jewellery brands to bookmark - From Pandora to Kimaï and Monica Vinader, these are the ...